The National Governors Association Center for Best Practices (NGA Center) hosted a meeting for states participating in the Prescription Drug Abuse Policy Academy. The meeting provided an opportunity to bring together the six states undertaking projects to reduce prescription drug abuse. The meeting focused on multiple strategies for building on current state efforts, including best practices for prescription drug monitoring programs (PDMPs), creating effective public education campaigns, educating providers about prescribing practices and providing treatment and recovery services. States also discussed the importance of data and evaluation. States discussed achievements and challenges and came away with a roadmap for moving their programs forward.


July 8, 2015

Welcome and Meeting Overview
Governor Peter Shumlin, Vermont
Jeff McLeod, program director, Homeland Security & Public Safety Division, NGA Center

Strategies for Reducing Prescription Drug Abuse and Overdose
This session provided an overview of state policy approaches to reducing prescription drug abuse.
Kelly Murphy, program director, Health Division, NGA Center
Paul Jarris, executive director, Association of State and Territorial Health Officials

A Review of Prescription Drug Monitoring Capabilities and State Efforts to Increase Their Use by Providers
This session highlighted the cutting edge of PDMP capabilities, provided actionable recommendations for integrating PDMPs with EHRs and addressed state efforts to increase PDMP usage by providers.
John Eadie, director, Prescription Monitoring Program Center of Excellence, Brandeis University
Sherry Green, CEO, Sherry L. Green & Associates, and co-founder, the National Alliance for Model State Drug Laws
Chad Zadrazil, director, Wisconsin Prescription Drug Monitoring Drug Program
Elyse Monroy, health and human services policy analyst, Nevada Governor’s Office

Opioid Addiction and the Emerging Threats of Heroin, Hepatitis C and HIV
Cece Spitznas, senior science policy advisor, Office of National Drug Control Policy

Breakout A: Understanding the Science of Pain and Identifying Evidence-Based Practices for Treating It
This session discussed the science of pain and treatment, as well as state policy approaches for educating and engaging providers.
Nancy Dunlap, physician-in-residence, NGA Center
Magdalena Naylor, director, Clinical Neuroscience Research Unit, University of Vermont
Kathy Paxton, director, West Virginia State Substance Abuse Services
Denzil Hawkinberry, physician, Community Care of West Virginia

Breakout B: Using Data to Inform Public Education
This session discussed innovative approaches for using data to inform public education efforts.
Christy Porucznik, associate professor and associate chief, Division of Public Health, Department of Family and Preventive Medicine, University of Utah
Denise Paone, director of research and surveillance; Bureau of Alcohol and Drug Use Prevention, Care and Treatment; New York City Department of Health and Mental Hygiene

Best Practices for Treatment
Speakers discussed pressing topics in the area of drug abuse recovery and treatment, including Medication Assisted Treatment (MAT) and peer-coaching recovery models.
Melinda Becker, legislative director, Health & Human Services Committee, NGA
Mark Ames, network coordinator, Vermont Recovery Network

Using Evaluation to Assess the Effectiveness of State Interventions
NGA and the Urban Institute kicked off Day 2 with a discussion on the importance of data and evaluation for measuring the effectiveness of prescription drug abuse efforts.
Jeff McLeod, program director, Homeland Security and Public Safety Division, NGA Center
Dave McClure, research associate, Justice Policy Center, The Urban Institute

State Example: Evaluating Kentucky’s Efforts to Reduce Prescription Drug Abuse
This session discussed results of the University of Kentucky’s evaluation of the state’s efforts to reduce prescription drug abuse. Speakers highlighted challenges with conducting an evaluation, lessons learned and recommendations for ensuring state evaluation efforts are effective.
Dave McClure, research associate, Justice Policy Center, The Urban Institute
Van Ingram, executive director, Kentucky Office of Drug Control Policy
John Eadie, director, Prescription Monitoring Program Center of Excellence, Brandeis University

Putting Evaluation to Work
During this session, state teams developed a logic model for evaluating one or more of their strategic initiatives aimed at reducing prescription drug abuse.

Dave McClure, research associate, Justice Policy Center, The Urban Institute


ONDCP Fact Sheet on Syringe Service Programs
This fact sheet from the Office of National Drug Control Policy (ONDCP) discusses the evidence for the effectiveness of syringe service programs and their role in preventing the spread of HIV and Hepatitis B and C.

SAMHSA FAQ on 42 CFR Part 2
This FAQ from the Substance Abuse and Mental Health Services Administration (SAMHSA) answers common questions about substance abuse confidentiality regulations (specifically 42 CFR Part 2) with regard to health information exchanges.

SAMHSA Letter on PDMPs in Opioid Treatment Programs
This letter from SAMHSA includes information on how states can improve use of state PDMPs by providers in opioid treatment programs. It also includes a case study from the Brandeis PDMP Center of Excellence on the use of PDMPs in these programs.

SAMHSA Guidance on 42 CFR Part 2 and HIPAA Privacy Regulations
This guidance from SAMHSA clarifies how substance abuse treatment programs must comply with 42 CFR Part 2 and HIPAA regulations and how these rules affect disclosure of patient information.